Advanced search
Publication Cover
International Reviews of Immunology Volume 21, 2002 - Issue 4-5
Submit an article Journal homepage
41
Views
17
CrossRef citations to date
0
Altmetric
Research Article

CYTOKINES IN EXPERIMENTAL HERPES SIMPLEX VIRUS INFECTION

VEIJO HUKKANEN Department of Virology, MediCity Research Laboratory, University of Turku, Turku, Finland
,
EEVA BROBERG Department of Virology, MediCity Research Laboratory, University of Turku, Turku, Finland
,
AIMO SALMI Department of Virology, MediCity Research Laboratory, University of Turku, Turku, Finland
&
JUHA-PEKKA ERÄLINNA Department of Neurology, University of Turku, Turku, Finland
Pages 355-371 | Published online: 03 Aug 2009

  • B. Roizman, Herpesviridae, in Fields Virology. B.N. Fields, D.M. Knipe, P.M. Howley, R.M. Chanock, J.L. Melnick, T.P. Monath, B. Roizman and S.E. Straus, (eds.). Philadelphia: Lippincott-Raven, 1996, Vol. 2, pp. 2221-2230.
  • P. Ward and B. Roizman, Evasion and obstruction. The central strategy of the interaction of human herpesviruses with host defenses, in Herpesuiruses and immunity. Medveczky et al. (eds.) New York: Plenum Press, 1998.
  • R. Whitley, Herpes simplex viruses, in Fields Virology. B.N. Fields, D.M. Knipe, P.M. Howley, R.M. Chanock, J.L. Melnick, T.P. Monath, B. Roizman and S.E. Straus, (eds.) Philadelphia: Lippincott-Raven, 1996, Vol. 2, pp. 2297-2342.
  • B. Roizman and A. Sears, Herpes simplex viruses and their replication, in Fields Virology. B.N. Fields, D.M. Knipe, P.M. Howley, R.M. Chanock, J.L. Melnick, T.P. Monath, B. Roizman and S.E. Straus, (eds.) Philadelphia: Lippincott-Raven, 1996, Vol. 2, pp. 2231-2295.
  • J. Stevens, E.K. Wagner, G. Devi-Rao, M. Cook and L. Feldman, RNA complementary to a herpesvirus a gene mRNA is prominent in latently infected neurons. Science, 235: 1056-1059, 1987.
  • M. Aubert and J. Blaho, Modulation of apoptosis during herpes simplex virus infection in human cells. Microbes Infect., 3: 1-8, 2001.
  • B. He, M. Gross and B. Roizman, The ?134.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1a to dephosphorylate the a subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. USA, 94: 843-848, 1997.
  • I. York, C. Roop, D. Andrews, S. Riddell, F. Graham and D. Johnson, A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8 + T lymphocytes. Cell, 77: 525-535, 1994.
  • A. Hill, P. Jugovic, I. York, G. Russ, J. Bennink, J. Yewdell, H. Ploegh and D. Johnson, Herpes simplex virus turns off TAP to evade host immunity. Nature, 375: 411-415, 1995.
  • M.J. Raftery, C.K. Behrens, A. Muller, P.H. Krammer, H. Walczak and G. Schonrich, Herpes simplex virus type 1 infection of activated cytotoxic T cells: Induction of fratricide as a mechanism of viral immune evasion. J. Exp. Med., 190: 1103-1114, 1999.
  • D.C. Johnson, M.C. Frame, M.W. Ligas, A.M. Cross and N.D. Stow, Herpes simplex virus immunoglobulin G Fc receptor activity depends on a complex of two viral glycoproteins, gE and gl. J. Virol., 62: 1347-1354, 1988.
  • R.L. Hendricks, T.M. Tumpey and A. Finnegan, IFN-gamma and IL-2 are protective in the skin but pathologic in the corneas of HSV-1-infected mice. J. Immunol., 149: 3023-3028, 1992.
  • A.R. Ellison, L. Yang, C. Voytek and T.P. Margolis, Establishment of latent herpes simplex virus type 1 infection in resistant, sensitive, and immunodeficient mouse strains. Virology, 268: 17-28, 2000.
  • J. Glorioso, N. DeLuca and D. Fink, Development and application of herpes simplex virus vectors for human gene therapy. Annu. Rev. Microbiol., 49: 675-710, 1995.
  • R. Furlan, P. Poliani, F. Galbiati, A. Bergami, L. Grimaldi, G. Comi, L. Adorini and G. Martino, Central nervous system delivery of interleukin 4 by a nonreplicative herpes simplex type 1 viral vector ameliorates autoimmune demyelination. Hum. Gene Ther., 9: 2605-2617, 1998.
  • E. Broberg, N. Setälä, M. Röyttä, J. -P. Erälinna, A. Salmi, B. He, B. Roizman and V. Hukkanen, Expression of interleukin-4 but not of interleukin-10 from a replicative herpes simplex virus type 1 viral vector precludes experimental allergic encephalomyelitis. Gene Ther., 8: 769-777, 2001.
  • G. Martino, R. Furlan, G. Comi and L. Adorini, The ependymal route to the CNS: An emerging gene therapy approach for MS. Trends Immunol., 22: 483-490, 2001.
  • C. Lopez, Genetics of natural resistance to herpesvirus infection in mice. Nature, 258: 152-153, 1975.
  • L. Kastrukoff, A. Lau and M. Puterman, Genetics of natural resistance to herpes simplex virus type 1 latent infection of the peripheral nervous system in mice. J. Gen. Virol., 67: 613-621, 1986.
  • Y.J. Gordon, J.L. C. McKnight, J.M. Ostrove, E. Romanowski and T. Araullo-Cruz, Host species and strain differences affect the ability of an ICPO deletion mutant to establish latency and spontaneously reactivate in vivo. Virology, 178: 469-477, 1990.
  • S. Hudson, R. Dix and J.W. Streilein, Induction of encephalitis in SJL mice by intranasal infection with herpes simplex virus type 1: A possible model of herpes simplex encephalitis in humans. J. Infect. Dis., 163: 720-727, 1991.
  • C. Shimeld, S. Efstathiou and T. Hill, Tracking the spread of a lacZ-tagged herpes simplex virus type 1 between the eye and the nervous system of the mouse: Comparison of primary and recurrent infection. J. Virol., 75: 5252-5262, 2001.
  • T. Margolis, F. Sedarati, A. Dobson, L. Feldman and J. Stevens, Pathways of viral gene expression during acute neuronal infection with HSV-1. Virology, 189: 150-160, 1992.
  • P. Speck and A. Simmons, Synchronous appearance of antigen-positive and latently infected neurons in spinal ganglia of mice infected with a virulent strain of herpes simplex virus. J. Gen. Virol., 73: 1281-1285, 1992.
  • E.K. Wagner, G. Devi-Rao, L. Feldman, A. Dobson, Y. -F. Zhang, W.M. Flanagan and J. Stevens, Physical characterization of the herpes simplex virus latency-associated transcript in neurons. J. Virol., 62: 1194-1202, 1988.
  • A. Dobson, F. Sederati, G. Devi-Rao, W.M. Flanagan, M. Farrell, J. Stevens, E.K. Wagner and L. Feldman, Identification of the latency-associated transcript promoter by expression of rabbit beta-globin mRNA in mouse sensory nerve ganglia latently infected with a recombinant herpes simplex virus. J. Virol., 63: 3844-3851, 1989.
  • V. Hukkanen, P. Heino, A. Sears and B. Roizman, Detection of herpes simplex virus latency-associated RNA in mouse trigeminal ganglia by in situ hybridization using nonradioactive digoxigenin-labeled DNA and RNA probes. Meth. MoI. Cell. Biol., 2: 70-81, 1990.
  • M. Lagunoff and B. Roizman, Expression of a herpes simplex virus 1 open reading frame antisense to the ?134.5 gene and transcribed by an RNA 3' coterminal with the unspliced latency-associated transcript. J. Virol., 68: 6021-6028, 1994.
  • M. Lagunoff and B. Roizman, The regulation of synthesis and properties of the protein product of open reading frame P of the herpes simplex virus 1 genome. J. Virol., 69: 3615-3623, 1995.
  • G. Randall, M. Lagunoff and B. Roizman, The product of ORF O located within the domain of herpes simplex virus 1 genome transcribed during latent infection binds to and inhibits in vitro binding of infected cell protein 4 to its cognate DNA site. Proc. Natl. Acad. Sci. USA, 94: 10379-10384, 1997.
  • N. Sawtell, Comprehensive quantitation of herpes simplex virus latency at the single-cell level. J. Virol., 71: 5423-5431, 1997.
  • N. Sawtell, The probability of in vivo reaction of herpes simplex virus type 1 increases with the number of latently infected neurons in the ganglia. J. Virol., 72: 6888-6892, 1998.
  • H. Cheng, T.M. Tumpey, H.F. Staats, N. van Rooijen, J.E. Oakes and R.N. Lausch, Role of macrophages in restricting herpes simplex virus type 1 growth after ocular infection. Invest. Ophthalmol. Vis. Sci., 41: 1402-1409, 2000.
  • C. Shimeld, J.L. Whiteland, S.M. Nicholls, E. Grinfeld, D.L. Easty, H. Gao and T.J. Hill, Immune cell infiltration and persistence in the mouse trigeminal ganglion after infection of the cornea with herpes simplex virus type 1. J. Neuroimmunol., 61:7-16, 1995.
  • I. Waley, H.P. Dienes, J. Bohl, J. Podlech and D. Falke, Correlation of virus replication, cytokine (TNF-alpha and IL-1) producing cells, neuronal necrosis and inflammation after intranasal infection of mice with herpes simplex virus strains of different virulence. Arch. Virol., 140: 1957-1967, 1995.
  • D.C. Tscharke and A. Simmons, Anti-CD8 treatment alters interleukin-4 but not interferon-gamma mRNA levels in murine sensory ganglia during herpes simplex virus infection. Brief report. Arch.Virol., 144: 2229-2238, 1999.
  • T. Liu, Q. Tang and R.L. Hendricks, Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection. J. Virol., 70: 264-271, 1996.
  • P. Kodukula, T. Liu, N.V. Rooijen, M.J. Jager and R.L. Hendricks, Macrophage control of herpes simplex virus type 1 replication in the peripheral nervous system. J. Immunol., 162: 2895-2905, 1999.
  • C. Shimeld, J. Whiteland, S. Nicholls, D. Easty and T. Hill, Immune cell infiltration in corneas of mice with recurrent herpes simplex virus disease. J. Gen. Virol., 77: 977-985, 1996.
  • C. Shimeld, J.L. Whiteland, N.A. Williams, D.L. Easty and T.J. Hill, Reactivation of herpes simplex virus type 1 in the mouse trigeminal ganglion: An in vivo study of virus antigen and immune cell infiltration. J. Gen. Virol., 77: 2583-2590, 1996.
  • C.M. Posavad, D.M. Koelle and L. Corey, Tipping the scales of herpes simplex virus reactivation: The important responses are local. Nat. Med., 4: 381-382, 1998.
  • W.P. Halford, B.M. Gebhardt and D.J. Carr, Persistent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus type 1. J. Immunol., 157: 3542-3549, 1996.
  • C. Shimeld, J.L. Whiteland, N.A. Williams, D.L. Easty and T.J. Hill, Cytokine production in the nervous system of mice during acute and latent infection with herpes simplex virus type 1. J. Gen. Virol., 78: 3317-3325, 1997.
  • J. He, H. Ichimura, T. Iida, M. Minami, K. Kobayashi, M. Kita, C. Sotozono, Y.I. Tagawa, Y. Iwakura and J. Imanishi, Kinetics of cytokine production in the cornea and trigeminal ganglion of C57BL/6 mice after corneal HSV-I infection. J. Interferon Cytokine Res., 19: 609-615, 1999.
  • C. Shimeld, D.L. Easty and T.J. Hill, Reactivation of herpes simplex virus type 1 in the mouse trigeminal ganglion: An in vivo study of virus antigen and cytokines. J. Virol., 73: 1767-1773, 1999.
  • T. Bartfai and M. Schultzberg, Cytokines in neuronal cell types. Neurochem. Int., 22: 435-444, 1993.
  • S.J. Hopkins and N.J. Rothwell, Cytokines and the nervous system I: Expression and recognition. TINS, 18: 83-88, 1995.
  • E.M. Cantin, D.R. Hinton, J. Chen and H. Openshaw, Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1. J. Virol., 69: 4898-4905, 1995.
  • W.P. Halford, L.A. Veress, B.M. Gebhardt and D.J. Carr, Innate and acquired immunity to herpes simplex virus type 1. Virology, 236: 328-337, 1997.
  • W.P. Halford, B.M. Gebhardt and D.J. Carr, Acyclovir blocks cytokine gene expression in trigeminal ganglia latently infected with herpes simplex virus type 1. Virology, 238: 53-63, 1997.
  • P.M. Smith, R.M. Wolcott, R. Chervenak and S.R. Jennings, Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma). Virology, 202: 76-88, 1994.
  • A.X. Holterman, K. Rogers, K. Edelmann, D.M. Koelle, L. Corey and C.B. Wilson, An important role for major histocompatibility complex class I-restricted T cells, and a limited role for gamma interferon, in protection of mice against lethal herpes simplex virus infection. J. Virol., 73: 2058-2063, 1999.
  • G. Lewandowski, M. Hobbs and A. Geller, Evidence that deficient IFN-gamma production is a biological basis of herpes simplex virus type-2 neurovirulence. J. Neuroimmunol., 81: 66-75, 1998.
  • E. Cantin, B. Tanamachi and H. Openshaw, Role for gamma interferon in control of herpes simplex virus type 1 reactivation. J. Virol., 73: 3418-3423, 1999.
  • E. Cantin, B. Tanamachi, H. Openshaw, J. Mann and K. Clarke, Gamma interferon (IFN-gamma) receptor null-mutant mice are more susceptible to herpes simplex virus type 1 infection than IFN-gamma ligand null-mutant mice. J. Virol., 73: 5196-5200, 1999.
  • J.A. Lekstrom Himes, R.A. LeBlanc, L. Pesnicak, M. Godleski and S.E. Straus, Gamma interferon impedes the establishment of herpes simplex virus type 1 latent infection but has no impact on its maintenance or reactivation in mice. J. Virol., 74: 6680-6683, 2000.
  • K.D. Geiger, T.C. Nash, S. Sawyer, T. Krahl, G. Patstone, J.C. Reed, S. Krajewski, D. Dalton, M.J. Buchmeier and N. Sarvetnick, Interferon-gamma protects against herpes simplex virus type I-mediated neuronal death. Virology, 238: 189-197, 1997.
  • D.M. Bouley, S. Kanangat, W. Wire and B.T. Rouse, Characterization of herpes simplex virus type-1 infection and herpetic stromal keratitis development in IFNgamma knockout mice. J. Immunol., 155: 3964-3971, 1995.
  • X. Han, P. Lundberg, B. Tanamachi, H. Openshaw, J. Longmate and E. Cantin, Gender influences herpes simplex virus type 1 infection in normal and gamma interferon-mutant mice. J. Virol., 75: 3048-3052, 2001.
  • D.A. Leib, TE. Harrison, K.M. Laslo, M.A. Machalek, N.J. Moorman and H.W. Virgin, Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo. J. Exp. Med., 189: 663-672, 1999.
  • R. Rampling, G. Cruickshank, V. Papanastassiou, J. Nicoll, D. Hadley, D. Brennan, R. Petty, A. MacLean, J. Harland, E. McKie, R. Mabbs and M. Brown, Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma. Gene Ther., 7: 859-866, 2000.
  • J. Chou, E. Kern, R. Whitley and B. Roizman, Mapping of herpes simplex virus-1 neurovirulence to ?134.5, a gene nonessential for growth in culture. Science, 250: 1262-1266, 1990.
  • D.J. Carr, Increased levels of IFN-gamma in the trigeminal ganglion correlate with protection against HSV-1-induced encephalitis following subcutaneous administration with androstenediol. J. Neuroimmunol., 89: 160-167, 1998.
  • A.M. Harandi, B. Svennerholm, J. Holmgren and K. Eriksson, Interleukin-12 (IL-12) and IL-18 are important in innate defense against genital herpes simplex virus type 2 infection in mice but are not required for the development of acquired gamma interferon-mediated protective immunity. J. Virol., 75: 6705-6709, 2001.
  • TH. Stumpf, C. Shimeld, D.L. Easty and T.J. Hill, Cytokine production in a murine model of recurrent herpetic stromal keratitis. Invest. Ophthal. Vis. Sci., 42: 372-378, 2001.
  • M. Hu, J. Dutt, V. Arrunategui Correa, S. Baltatzis and C.S. Foster, Cytokine mRNA in BALB/c mouse corneas infected with herpes simplex virus. Eye, 13: 309-313, 1999.
  • K. Ikemoto, R.B. Pollard, T Fukumoto, M. Morimatsu and F. Suzuki, Small amounts of exogenous IL-4 increase the severity of encephalitis induced in mice by the intranasal infection of herpes simplex virus type 1. J. Immunol., 155: 1326-1333, 1995.
  • R. Jackson, A. Ramsay, C. Christensen, S. Beaton, D. Hall and I. Ramshaw, Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox. J. Virol., 75: 1205-1210, 2001.
  • X.T. Van, M. Zhuang, J.E. Oakes and R.N. Lausch, Autocrine action of IL-10 suppresses proinflammatory mediators and inflammation in the HSV-1-infected cornea. J. Leukoc. Biol., 69: 149-157, 2001.
  • J. -P. Erälinna, M. Röyttä, V. Hukkanen, D. Zinhu, A.A. Salmi and R. Salonen, Selective downregulation of Th1 response by Linomide reduces autoimmunity but increases susceptibility to viral infection in BALB/c and SJL mice. J. Neuroimmunol., 88: 165-176, 1998.
  • C.J. Harrison, R.L. Miller and D.I. Bernstein, Reduction of recurrent HSV disease using imiquimod alone or combined with a glycoprotein vaccine. Vaccine, 19: 1820-1826, 2001.
  • K.L. Mossman, P.F. Macgregor, J.J. Rozmus, A.B. Goryachev, A.M. Edwards and J.R. Smiley, Herpes simplex virus triggers and then disarms a host antiviral response. J. Virol., 75: 750-758, 2001.
  • K.A. Cassady, M. Gross and B. Roizman, The second-site mutation in the herpes simplex virus recombinants lacking the gamma 34.5 genes precludes shutoff of protein synthesis by blocking the phosphorylation of eIF-2alpha. J. Virol., 72: 7005-7011, 1998.
  • S.L. Tan and M.G. Katze, HSV.com: Maneuvering the internetworks of viral neuropathogenesis and evasion of the host defense. Proc. Natl. Acad. Sci. USA, 97: 5684-5686, 2000.
  • N.A. Kuklin, M. Daheshia, P.C. Marconi, D.M. Krisky, R.J. Rouse, J.C. Glorioso, E. Manican and B.T. Rouse, Modulation of mucosal and systemic immunity by enteric administration of nonreplicating herpes simplex virus expressing cytokines. Virology, 240: 245-253, 1998.
  • J. Parker, G.Y. Gillespie, C. Love, S. Randall, R. Whitley and J.M. Markert, Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors. Proc. Natl. Acad. Sci. USA, 97: 2208-2213, 2000.
  • R. Furlan, E. Brambilla, F. Ruffini, P. Poliani, A. Bergami, P. Marconi, D. Franciotta, G. Penna, G. Comi, L. Adorini and G. Martino, Intrathecal delivery of IFN-? protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous systeminfiltrating lymphocytes. J. Immunol., 167: 1821-1829, 2001.
  • S. Andreansky, B. He, J. van Cott, J. McGhee, J. Markert, G.Y. Gillespie, B. Roizman and R.J. Whitley, Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins. Gene Ther., 5: 121-130, 1998.
  • S. Noisakran, W.P. Halford, L. Veress and D.J. Carr, Role of the hypothalamic pituitary adrenal axis and IL-6 in stress-induced reactivation of latent herpes simplex virus type 1. J. Immunol., 160: 5441-5447, 1998.
  • D.J. Carr, S. Noisakran, W.P. Halford, N. Lukacs, V. Asensio and I.L. Campbell, Cytokine and chemokine production in HSV-1 latently infected trigeminal ganglion cell cultures: Effects of hyperthermic stress. J. Neuroimmunol., 85: 111-121, 1998.
  • S.H. Chen, D.A. Garber, P.A. Schaffer, D.M. Knipe and D.M. Coen, Persistent elevated expression of cytokine transcripts in ganglia latently infected with herpes simplex virus in the absence of ganglionic replication or reactivation. Virology, 278: 207-216, 2000.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.